Cue Biopharma Inc buy Stifel Nicolaus
Start price
09.04.24
/
50%
€1.65
Target price
09.04.25
€7.35
Performance (%)
-42.12%
Price
01.07.24
€0.96
Summary
This prediction is currently active. The BUY prediction by Stifel_Nicolaus for Cue Biopharma Inc is performing very badly with a performance of -42.12%. This prediction currently runs until 09.04.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cue Biopharma Inc | -24.206% | -24.206% |
iShares Core DAX® | -0.145% | -2.221% |
iShares Nasdaq 100 | 1.296% | 9.035% |
iShares Nikkei 225® | 1.282% | 3.119% |
iShares S&P 500 | 0.442% | 5.429% |
Comments by Stifel_Nicolaus for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.
Ratings data for CUE provided by MarketBeat